163 related articles for article (PubMed ID: 29689094)
1. The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia.
Spiess B; Naumann N; Galuschek N; Rinaldetti S; Kossak-Roth U; Tarnopolscaia I; Felde E; Fabarius A; Hofmann WK; Saußele S; Seifarth W
PLoS One; 2018; 13(4):e0196326. PubMed ID: 29689094
[TBL] [Abstract][Full Text] [Related]
2. A review of the challenge in measuring and standardizing BCR-ABL1.
Yu S; Cui M; He X; Jing R; Wang H
Clin Chem Lab Med; 2017 Aug; 55(10):1465-1473. PubMed ID: 28222016
[TBL] [Abstract][Full Text] [Related]
3. Design and analytic validation of BCR-ABL1 quantitative reverse transcription polymerase chain reaction assay for monitoring minimal residual disease.
Jennings LJ; Smith FA; Halling KC; Persons DL; Kamel-Reid S;
Arch Pathol Lab Med; 2012 Jan; 136(1):33-40. PubMed ID: 22208485
[TBL] [Abstract][Full Text] [Related]
4. Standardisation of molecular monitoring for chronic myeloid leukaemia.
Cross NC
Best Pract Res Clin Haematol; 2009 Sep; 22(3):355-65. PubMed ID: 19959086
[TBL] [Abstract][Full Text] [Related]
5. Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients.
Guo JQ; Lin H; Kantarjian H; Talpaz M; Champlin R; Andreeff M; Glassman A; Arlinghaus RB
Leukemia; 2002 Dec; 16(12):2447-53. PubMed ID: 12454751
[TBL] [Abstract][Full Text] [Related]
6. Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA.
Brown JT; Beldorth IJ; Laosinchai-Wolf W; Fahey ME; Jefferson KL; Ruskin AK; Roth JJ; Cai L; Watt CD; Press RD; Yang F; Hedges JB; Andruss BF
J Mol Diagn; 2019 Jul; 21(4):718-733. PubMed ID: 31026597
[TBL] [Abstract][Full Text] [Related]
7. Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples.
Stock W; Yu D; Karrison T; Sher D; Stone RM; Larson RA; Bloomfield CD
Int J Oncol; 2006 May; 28(5):1099-103. PubMed ID: 16596225
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid Leukemia.
Franke GN; Maier J; Wildenberger K; Cross M; Giles FJ; Müller MC; Hochhaus A; Niederwieser D; Lange T
J Mol Diagn; 2020 Jan; 22(1):81-89. PubMed ID: 31669230
[TBL] [Abstract][Full Text] [Related]
9. Cepheid xpert monitor platform for the confirmation of BCR-ABL1 IS conversion factors for the molecular monitoring of chronic myeloid leukaemia.
Gerrard G; Foong HE; Mudge K; Alikian M; Apperley JF; Foroni L
Leuk Res; 2016 Oct; 49():47-50. PubMed ID: 27552679
[TBL] [Abstract][Full Text] [Related]
10. Absolute quantification of BCR-ABL1 fusion transcripts in pediatric chronic myeloid leukemia.
Tang Y; Wei X; Chen J; Du Y; Chu H; Mao L; Chen J; Xu Q; Tang J; Shen S; Mao M
Leuk Lymphoma; 2016 Sep; 57(9):2216-8. PubMed ID: 27095369
[No Abstract] [Full Text] [Related]
11. Quantitative real-time polymerase chain reaction as an efficient molecular tool for detecting minimal residual disease in Moroccan chronic myeloid leukemia patients.
Moumen A; Dehbi H; Kottwitz D; El Amrani M; Bouchoutrouch N; El Hadi H; Quessar A; Benchekroun S; Nadifi S; Sefrioui H
Genet Mol Res; 2015 Feb; 14(1):1044-55. PubMed ID: 25730044
[TBL] [Abstract][Full Text] [Related]
12. Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes.
Bolufer P; Sanz GF; Barragán E; Sanz MA; Cervera J; Lerma E; Senent L; Moreno I; Planelles MD
Haematologica; 2000 Dec; 85(12):1248-54. PubMed ID: 11114130
[TBL] [Abstract][Full Text] [Related]
13. Qualitative and quantitative evaluation of the BCR-ABL fusion gene in chronic myelogenous leukemia by flourescence in situ hybridization and molecular genetic methods.
Ozemri Sag S; Yakut T; Gorukmez O; Gorukmez O; Ture M; Karkucak M; Gulten T; Ali R
Genet Test Mol Biomarkers; 2015 Oct; 19(10):584-8. PubMed ID: 26308792
[TBL] [Abstract][Full Text] [Related]
14. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
[TBL] [Abstract][Full Text] [Related]
15. Detection and quantification of BCR-ABL1 fusion transcripts by droplet digital PCR.
Jennings LJ; George D; Czech J; Yu M; Joseph L
J Mol Diagn; 2014 Mar; 16(2):174-9. PubMed ID: 24389534
[TBL] [Abstract][Full Text] [Related]
16. Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNA.
Bartley PA; Ross DM; Latham S; Martin-Harris MH; Budgen B; Wilczek V; Branford S; Hughes TP; Morley AA
Int J Lab Hematol; 2010 Dec; 32(6 Pt 1):e222-8. PubMed ID: 20491997
[TBL] [Abstract][Full Text] [Related]
17. Analysis of major BCR-ABL1 mRNA by digital polymerase chain reaction is useful for prediction of international scale.
Furuya D; Moriai M; Koizumi Y; Endo T; Asanuma K; Yanagihara N; Takahashi S
Int J Clin Oncol; 2019 Jul; 24(7):871-875. PubMed ID: 30798394
[TBL] [Abstract][Full Text] [Related]
18. Programme for Harmonization to the International Scale in Latin America for BCR-ABL1 quantification in CML patients: findings and recommendations.
Ruiz MS; Sánchez MB; Vera Contreras YM; Agrielo E; Alonso M; Altuna ME; Anchordoqui MS; Asinari M; Bonetto ME; Camargo M; Giere I; González J; Granda Alacote AC; Guerra J; Gutiérrez M; Maldonado C; Makiya R; Manrique G; Monaco ME; Rozo JC; Santamaría C; Seravalle A; Zea O; Zubillaga MN; Mordoh J; Larripa I; Bianchini M
Clin Chem Lab Med; 2020 Nov; 58(12):2025-2035. PubMed ID: 32374276
[TBL] [Abstract][Full Text] [Related]
19. Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay.
Goh HG; Lin M; Fukushima T; Saglio G; Kim D; Choi SY; Kim SH; Lee J; Lee YS; Oh SM; Kim DW
Leuk Lymphoma; 2011 May; 52(5):896-904. PubMed ID: 21338281
[TBL] [Abstract][Full Text] [Related]
20. Conversion, correction, and International Scale standardization: results From a Multicenter External Quality Assessment Study for BCR-ABL1 testing.
Griffiths M; Patton SJ; Grossi A; Clark J; Paz MF; Labourier E;
Arch Pathol Lab Med; 2015 Apr; 139(4):522-9. PubMed ID: 25061833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
